The anti-condyloma acuminatum effects of interferon-inducible protein 10 in vitro

Int J Dermatol. 2009 Feb;48(2):136-41. doi: 10.1111/j.1365-4632.2009.03776.x.

Abstract

Background: Interferon-inducible protein 10 (IP-10) has been reported to show an effective antiviral and antineoplastic role in various murine models.

Aim: To investigate the anti-condyloma acuminatum effect and human papillomavirus (HPV)-inhibiting efficacy of a recombinant plasmid encoding IP-10 in vitro.

Methods: A recombinant plasmid DNA carrying IP-10 cDNA was constructed. Condyloma acuminatum tissue particles were transfected with IP-10 and examined for apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining and flow cytometry techniques. Relative real-time polymerase chain reaction (PCR) was used to validate the HPV inhibited level of the treatment groups. Immunohistochemistry was used to determine the IP-10 expression on condyloma acuminatum tissues.

Results: Transfected IP-10 was expressed mainly in the cytoplasm of the condyloma acuminatum tissues. Plentiful apoptosis was observed in condyloma acuminatum tissues transfected with IP-10. In addition, HPV expression was lower in IP-10-treated tissues than in control tissues.

Conclusions: These observations suggest that IP-10 has strong anti-condyloma acuminatum effects, inducing apoptosis and inhibiting HPV, and therefore may be a novel and potentially effective therapy for condyloma acuminatum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apoptosis
  • Chemokine CXCL10 / genetics*
  • Condylomata Acuminata / therapy*
  • Condylomata Acuminata / virology
  • Female
  • Flow Cytometry
  • Gene Expression
  • Genetic Therapy / methods*
  • Human papillomavirus 11*
  • Human papillomavirus 6*
  • Humans
  • In Situ Nick-End Labeling
  • In Vitro Techniques
  • Plasmids
  • Recombinant Proteins / genetics
  • Transfection

Substances

  • CXCL10 protein, human
  • Chemokine CXCL10
  • Recombinant Proteins